Harnessing Disruptive CAR & TCR Based Cell Technologies to Supercharge Safe, Effective & Globally Accessible Cell Immunotherapies in Oncology & Beyond

The 7th Annual CAR-TCR Summit returns in 2022 as the industry-leading comprehensive forum with one goal: to engineer a disease-free world.

As the industry reaches an inflection point and CAR-TCR therapies enter the commercial setting at increasing velocity, now is the time to join with all the key stakeholders to share strategies from early phase development to market access and commercial readiness. Gain end-to-end insights from established thought leaders, and the innovators bringing disruptive technologies from bench to bedside, and from vein to vein.

Across 4 days of carefully curated sessions, we will gather with 150+ CAR and TCR cell therapy VIPs that will lead you in discussions from commercial pipeline development to the ground-breaking approaches being pioneered by the next generation of leaders.

Explore iPSC-derived constructs, novel allogeneic approaches, supercharging therapies against solid tumor indications and integrate automation and streamlined manufacturing for consistency at scale, with
reduced cost of goods.

You can’t afford to miss the 7th Annual CAR-TCR Summit as we bring you more speakers, more content and more exclusive insights than ever before!

A Snapshot of the 150+ Leading Speakers Who Joined Us in 2021

Gary Lee

Chief Scientific Officer

Senti Biosciences Inc.

Janet Lynch Lambert

CEO

Alliance for Regenerative Medicine

Peter Marks

Director - Biologics Evaluation & Research

US Food & Drug Administration (FDA)

Steven Harr

President, Co-Founder & Chief Executive Officer

Sana Biotechnology

Tam Soden

Executive Director & Global Head of Quality Control

Kite Pharma Inc

Adrian Bot

Vice President - Scientific Affairs & Translational Medicine

Kite Pharma Inc

Dolores J. Schendel

Chief Executive Officer & Chief Scientific Officer

Medigene AG

Eric Ostertag

Chief Executive Officer

Poseida Therapeutics

Jennifer chow

COO

Chimeric Therapeutics

Steven Harr

President, Co-Founder & Chief Executive Officer

Sana Biotechnology

Axel Hoos

Senior Vice President & Head of Therapeutic Area Oncology, Research, Development & Governance Chair

GlaxoSmithKline

Heather Erickson

Vice President - Supply Chain Management & Business Operations

Sangamo Therapeutics

Rachel Haurwitz

President & Chief Executive Officer

Caribou Biosciences

Renier Brentjens

Director, Cellular Therapeutics

Memorial Sloan Kettering Cancer Center

Stefan Hendriks

Global Head of Cell & Gene

Novartis Oncology

Lead Partner:

Expertise Partners:

Explore More Events in the CAR-TCR Series

As part of the CAR-TCR Series, we are running events in Europe, and deep-dive meetings focused on key challenges to the industry. Please visit the individual event pages for more information.

February 22-24, 2022 | London, UK